Search

Your search keyword '"Missale G"' showing total 708 results

Search Constraints

Start Over You searched for: Author "Missale G" Remove constraint Author: "Missale G"
708 results on '"Missale G"'

Search Results

2. OC.05.7: CHOLESTASIS IMPACTS ON PERFORMANCE OF NON INVASIVE TESTS FOR RULING OUT HIGH-RISK ESOPHAGEALVARICES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED ADVANCED CHRONIC LIVER DISEASE

Catalog

Books, media, physical & digital resources

4. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

5. Metabolic dysfunction and DNA damage of exhausted tumor-infiltrating CD8 T-cells in hepatocellular carcinoma

6. Predictors of extrahepatic progression in patients with hepatocellular carcinoma receiving transarterial chemoembolization

7. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

8. Survey on hepatic sarcoidosis in Italy

9. Preoperative predictors of recurrence beyond Milan criteria in hepatocellular carcinoma patients treated with frontline liver resection

10. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro

11. Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications

13. Pattern of macrovascular invasion in hepatocellular carcinoma

14. Antiviral Cell-Mediated Immune Responses During Hepatitis B and Hepatitis C Virus Infections

19. Years of life that could be saved from prevention of hepatocellular carcinoma

20. Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome

21. Cholestasis impacts on performance of non invasive tests for ruling out high-risk esophageal varices in patients with primary biliary cholangitis and compensated advanced chronic liver disease

22. Hepatic sarcoidosis:an Italian multicenter study

24. Immune pathogenesis of hepatitis B

25. Infection Control Practices and Outcomes of Endoscopy Units in the Lombardy Region of Italy A Survey From the Italian Society of Digestive Endoscopy During COVID-19 Spread

26. Pattern of macrovascular invasion in hepatocellular carcinoma

27. The changing scenario of hepatocellular carcinoma in Italy: an update

28. Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter

31. Endoscopy units and the COVID-19 Outbreak: A Multi-Center Experience from Italy

32. Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy

34. Pattern of macrovascular invasion in patients with hepatocellular carcinoma influences treatment and outcome

38. Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma

39. T03.02.8 DUODENOSCOPE-RELATED INFECTIONS: AN ITALIAN PICK IN 2019

41. 1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients

42. DUODENOSCOPE-RELATED INFECTIONS: AN ITALIAN PICK IN 2019

44. Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study

45. Metabolic disorders across hepatocellular carcinoma in Italy

47. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres

49. AISF position paper on HCV in immunocompromised patients